dr. tolaney discusses unmet needs in er breast cancer
Published 6 years ago • 109 plays • Length 1:10Download video MP4
Download video MP3
Similar videos
-
1:11
dr. sparano discusses unmet needs in metastatic breast cancer
-
1:24
dr. tolaney discusses pertuzumab in her2 breast cancer
-
1:20
dr tolaney on ongoing clinical trials in early-stage her2 breast cancer
-
1:38
dr. tolaney on cns recurrence in her2 breast cancer
-
1:08
dr. tolaney discusses the role of chemotherapy in her2 breast cancer
-
2:06
dr. tolaney on deescalating therapy in stage i her2 breast cancer
-
0:57
dr. tolaney on trials investigating cabozantinib in breast cancer
-
1:39
dr. tolaney on sequencing strategies in metastatic her2 breast cancer
-
1:39
dr. tolaney on novel approaches in treating her2-positive breast cancer
-
1:39
dr tolaney on standard frontline treatment approaches in her2 breast cancer
-
2:06
unmet needs and cdk4/6 inhibitors in hr /her2- early breast cancer
-
1:00
dr. tolaney on remaining questions with cdk4/6 inhibitors in hr /her2- breast cancer
-
1:40
dr. tolaney discusses neratinib in her2 breast cancer
-
1:12
dr. graff underscores unmet needs in esr1-mutated breast cancer
-
1:16
dr. tolaney on platinum-based therapy in neoadjuvant setting of tnbc
-
0:49
dr. tolaney on the current treatment landscape for her2 breast cancer
-
1:11
unmet needs in the use of cdk4/6 inhibitors in early-stage hr /her2- breast cancer
-
7:37
dr. tolaney highlights new breast cancer combination therapies
-
1:25
dr. tolaney on the neoadjuvant therapy for her2-positive breast cancer